MedPath

Effect of Magnesium on Severity of Pain and Spasticity

Phase 2
Conditions
cerebral palsy.
Registration Number
IRCT20190817044550N1
Lead Sponsor
Sponsor Vice-chancellor of research, Islamic Azad University, Faculty of Medicine, Branch of Yazd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
31
Inclusion Criteria

patients with spastic cerebral palsy
children in the age of 2 to 17 years old

Exclusion Criteria

Botox injection for at least 6 months
The use of muscle relaxant drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Faces Pain Scale scores. Timepoint: 6 months after patients entered to the study. Method of measurement: FPS test.;Modified Ashworth scale scores. Timepoint: 6 months after patients entered to the study. Method of measurement: MAS test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath